CAR-T cell: an epitome for the cure of hematologic malignancies

There is an increasing reliance on modern cancer therapies on immunotherapeutic approaches such as immune checkpoint inhibitors and adoptive cell therapy (ACT), which includes tumor-infiltrating lymphocytes (TILs), T cell receptor (TCR)-modified T cells, and chimeric antigen receptor (CAR). CAR-T c...

Full description

Bibliographic Details
Main Authors: Mohammad Afeef, Shreya Bhattacharyya
Format: Article
Language:English
Published: TMKarpinski Publisher, Tomasz M. Karpiński 2022-05-01
Series:European Journal of Biological Research
Subjects:
Online Access:https://journals.tmkarpinski.com/index.php/ejbr/article/view/529